DPDoctor's PassportEducation
Educational draft · awaiting clinical reviewUse Rapid for revision, not patient-care decisions. Check current national and local guidance and the BNF or BNFC before acting.
RapidWPWdelta waveshort PRAVRTpre-excited AFaccessory pathwayablation

Wolff-Parkinson-White syndrome and pre-excitation

Essential points for quick revision.

!
Escalate

An irregular broad-complex tachycardia in a patient with pre-excitation may be pre-excited AF and can deteriorate to ventricular fibrillation. If unstable, perform immediate synchronised cardioversion; if pulseless, follow the shockable cardiac-arrest algorithm.

Synopsis

Recognise ventricular pre-excitation, manage AV re-entry and pre-excited atrial fibrillation safely, and identify who needs electrophysiology risk assessment or ablation.

  • Pre-excitation means an accessory atrioventricular pathway conducts to the ventricle outside the AV node; WPW syndrome is pre-excitation plus symptomatic tachyarrhythmia.
  • The sinus-rhythm ECG classically shows a short PR interval, slurred initial QRS upstroke (delta wave) and a widened QRS.
  • Orthodromic AV re-entrant tachycardia is usually regular and narrow because antegrade conduction uses the AV node; antidromic AVRT is broad.

Key red flags

Pre-excited AF

An irregular broad tachycardia with changing QRS morphology and very short RR intervals is the critical pattern.

Investigation priorities

01
12-lead ECG in sinus rhythmFirst step

Confirm and localise pre-excitation and look for alternative conduction disease.

Management branches

regular-narrowStable regular narrow tachycardia

The rhythm is regular, QRS is under 120 ms and there is no evidence of pre-excited AF.

  1. Record a 12-lead ECG and perform vagal manoeuvres while monitoring continuously.
  2. If unsuccessful and there is no pre-excitation in the tachycardia, give adenosine 6 mg as a very rapid IV bolus followed by a flush.

Key medicines

AdenosineRCUK March 2026: 6 mg by very rapid IV bolus, then 12 mg if unsuccessful, then 18 mg if still unsuccessful, each followed by a rapid flush and given with continuous ECG recording. This resuscitation-algorithm sequence differs from the cited product SmPC's licensed 3 mg, 6 mg, then 12 mg sequence.
ProcainamideRCUK: 10-15 mg/kg IV over 20 minutes, maximum 1 g, with continuous ECG and blood-pressure monitoring.
Open full textbook Answer 2 questionsCardiology check
Sources and review status6 sources · checked 27 Aug 2026 · clinical review pending
Sources

Sources and review status

National guidance is shown before implementation-dependent detail. Typical adult dose examples remain subject to patient factors, contraindications and the live BNF or specialist protocol. Source check completed 27 Aug 2026; clinical approval remains outstanding.

Authoring stateRapid draftClinical stateAwaiting reviewJurisdictionUnited Kingdom